Genmab A/S (GMAB) Reports 2024 Net Sales of DARZALEX of $11.67B

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. ENOV
4. AON
5. AZN
6. BLSM
7. GPRO
8. KRMN
9. GRMN
10. SRI

Go back to Genmab A/S (GMAB) Reports 2024 Net Sales of DARZALEX of $11.67B

Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024

January 22, 2025 6:23 AM EST

Company Announcement

Net sales of DARZALEX® in 2024 totaled USD 11,670 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.)

COPENHAGEN, Denmark; January 22, 2025 Genmab A/S (Nasdaq: GMAB) announced today... More